Immunostaining and time‑lapse analysis of vinblastine‑induced paracrystal formation in human A549 cells

Nakamura,Yuka; Ishigaki,Yasuhito

doi:10.3892/ol.2014.2549

Immunostaining and time‑lapse analysis of vinblastine‑induced paracrystal formation in human A549 cells

Authors:
- Yuka Nakamura
- Yasuhito Ishigaki
View Affiliations

Affiliations: Medical Research Institute, Kanazawa Medical University, Ishikawa 920‑0293, Japan
Published online on: September 18, 2014 https://doi.org/10.3892/ol.2014.2549
Pages: 2387-2392

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vinblastine is a vinca alkaloid that binds to tubulin and inhibits microtubule formation in cells. Vinblastine treatment results in the formation of paracrystalline aggregates in the cells, which are formed from tightly packed tubulin molecules. Mitotic spindle assemblies in treated cells are disrupted and cell cycle progression is arrested at the mitosis phase. Vinblastine is therefore widely used for cancer treatment. However, the mechanism underlying paracrystal formation has not been fully elucidated. The present study attempted to observe paracrystal formation in human A549 cells. Initally, paracrystal formation was detected using the anti-tubulin antibody. Secondly, the exogenousuly expressed RFP-conjugated tubulin also formed paracrystals. Additionally, immunostaining with the anti-RBM8A antibody overlapped with paracrystal images obtained from RFP conjugated tubulin. This suggested that the localization of the RBM8A proteins was adjacent to the tubulin molecules prior to vinblastine treatment. Furthermore, a time‑lapse analysis was developed for paracrystal formation in viable human A549 cells. This was achieved using exogenous expression of fluorescent proteins conjugated with tubulin and time‑lapse microscopy. It may be concluded that the indicated method was successful for the real‑time analysis of paracrystal formation in human cells.

View Figures

View References

1	Moudi M, Go R, Yien CY and Nazre M: Vinca alkaloids. Int J Prev Med. 4:1231–1235. 2013.
2	Nelson RL: The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer. Med Pediatr Oncol. 10:115–127. 1982.
3	Duggan DB, Petroni GR, Johnson JL, et al: Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial. J Clin Oncol. 21:607–614. 2003.
4	Ladisch S, Gadner H, Aricò M, et al: LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 23:107–110. 1994.
5	Epstein JB: Treatment of oral Kaposi sarcoma with intralesional vinblastine. Cancer. 71:1722–1725. 1993.
6	Einhorn LH: Curing metastatic testicular cancer. Proc Natl Acad Sci USA. 99:4592–4595. 2002.
7	Woodcock TM, Blumenreich MS, Richman SP, Kubota TT, Gentile PS and Allegra JC: Combination chemotherapy with cis-diamminedichloroplatinum and vinblastine in advanced non-small cell lung cancer. J Clin Oncol. 1:247–250. 1983.
8	Kovacs K and Horvath E: Vinblastine-induced ultrastructural changes in perisinusoidal cells of the rat liver. Res Exp Med (Berl). 165:245–249. 1975.
9	Shiino M: Ultrastructural observation of paracrystalline aggregates of microtubules in anterior pituitary cells of the chinchilla (Chinchilla laniger). Cell Tissue Res. 213:433–440. 1980.
10	De Brabander M, De May J, Joniau M and Geuens G: Ultrastructural immunocytochemical distribution of tubulin in cultured cells treated with microtubule inhibitors. Cell Biol Int Rep. 1:177–183. 1977.
11	Shiino M and Rennels EG: Vinblastine-induced microtubular paracrystals in prolactin cells of anterior pituitary gland of lactating rats. Am J Anat. 144:399–405. 1975.
12	Nogales E, Medrano FJ, Diakun GP, Mant GR, Towns-Andrews E and Bordas J: The effect of temperature on the structure of vinblastine-induced polymers of purified tubulin: detection of a reversible conformational change. J Mol Biol. 254:416–430. 1995.
13	Brockstedt U, Dobra K, Nurminen M and Hjerpe A: Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements. Exp Cell Res. 274:235–245. 2002.
14	Salicioni AM, Xi M, Vanderveer LA, et al: Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor. Genomics. 69:54–62. 2000.
15	Lau CK, Diem MD, Dreyfuss G and Van Duyne GD: Structure of the Y14-Magoh core of the exon junction complex. Curr Biol. 13:933–941. 2003.
16	Chuang TW, Chang WL, Lee KM and Tarn WY: The RNA-binding protein Y14 inhibits mRNA decapping and modulates processing body formation. Mol Biol Cell. 24:1–13. 2013.
17	Le Hir H, Gatfield D, Braun IC, Forler D and Izaurralde E: The protein Mago provides a link between splicing and mRNA localization. EMBO Rep. 2:1119–1124. 2001.
18	Sudo H, Tsuji AB, Sugyo A, et al: Knockdown of COPA, identified by loss-of-function screen, induces apoptosis and suppresses tumor growth in mesothelioma mouse model. Genomics. 95:210–216. 2010.
19	Ishigaki Y, Nakamura Y, Tatsuno T, et al: Depletion of RNA-binding protein RBM8A (Y14) causes cell cycle deficiency and apoptosis in human cells. Exp Biol Med (Maywood). 238:889–897. 2013.
20	Ishigaki Y, Nakamura Y, Tatsuno T, Hashimoto M, Iwabuchi K and Tomosugi N: RNA-binding protein RBM8A (Y14) and MAGOH localize to centrosome in human A549 cells. Histochem Cell Biol. 141:101–109. 2014.
21	Kost TA, Condreay JP and Jarvis DL: Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol. 23:567–575. 2005.
22	Kost TA and Condreay JP: Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20:173–180. 2002.
23	Shukla S, Schwartz C, Kapoor K, Kouanda A and Ambudkar SV: Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells. Drug Metab Dispos. 40:304–312. 2012.
24	Araki R, Jincho Y, Hoki Y, et al: Conversion of ancestral fibroblasts to induced pluripotent stem cells. Stem Cells. 28:213–220. 2010.
25	Sakaue-Sawano A, Kobayashi T, Ohtawa K and Miyawaki A: Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol. 12:22011.
26	Ben-Ze’ev A, Farmer SR and Penman S: Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell. 17:319–325. 1979.
27	Wehland J, Henkart M, Klausner R and Sandoval IV: Role of microtubules in the distribution of the Golgi apparatus: effect of taxol and microinjected anti-alpha-tubulin antibodies. Proc Natl Acad Sci USA. 80:4286–4290. 1983.
28	Sharp JA, Plant JJ, Ohsumi TK, Borowsky M and Blower MD: Functional analysis of the microtubule-interacting transcriptome. Mol Biol Cell. 22:4312–4323. 2011.
29	Sakaue-Sawano A, Ohtawa K, Hama H, Kawano M, Ogawa M and Miyawaki A: Tracing the silhouette of individual cells in S/G2/M phases with fluorescence. Chem Biol. 15:1243–1248. 2008.
30	Sakaue-Sawano A, Kurokawa H, Morimura T, et al: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 132:487–498. 2008.